Literature DB >> 1569150

Detection of mutations in the human insulin gene by single strand conformation polymorphisms.

M Kishimoto1, H Sakura, K Hayashi, Y Akanuma, Y Yazaki, M Kasuga, T Kadowaki.   

Abstract

Single strand conformation polymorphisms (SSCP) is the method by which mutations can be detected in DNA amplified by the polymerase chain reaction (PCR). This method utilizes the fact that the electrophoretic mobility of single stranded DNA under nondenaturing condition depends not only on its size but also on its conformation. We examined whether this technique could detect five mutations that had previously been identified in the insulin genes of patients with abnormal insulin or familial hyperproinsulinemia. Five mutant insulin genes were constructed by site directed mutagenesis, and the cloned mutant insulin genes were amplified by PCR. All five mutations were detected because they were associated with shifts in the electrophoretic mobility of the DNA fragments. In addition, we analyzed amplified genomic DNA from a patient who is heterozygotes for the Insulin Wakayama mutation A3(Val----Leu). This mutation was also detected by the SSCP technique. We conclude that PCR-SSCP method is a simple, fast, and efficient method for detection of mutations in the human insulin gene.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1569150     DOI: 10.1210/jcem.74.5.1569150

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

Review 1.  Pathophysiology of non-insulin-dependent diabetes and the search for candidate genes: dangerous liaisons?

Authors:  F Barbetti
Journal:  Acta Diabetol       Date:  1996-12       Impact factor: 4.280

2.  PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus.

Authors:  G Condorelli; G Vigliotta; C Iavarone; M Caruso; C G Tocchetti; F Andreozzi; A Cafieri; M F Tecce; P Formisano; L Beguinot; F Beguinot
Journal:  EMBO J       Date:  1998-07-15       Impact factor: 11.598

Review 3.  Phosphoprotein enriched in astrocytes (PEA)-15: a potential therapeutic target in multiple disease states.

Authors:  Fiona H Greig; Graeme F Nixon
Journal:  Pharmacol Ther       Date:  2014-03-20       Impact factor: 12.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.